Adequate thyroid-stimulating hormone levels after levothyroxine discontinuation in the follow-up of patients with well-differentiated thyroid carcinoma

Archives of Medical Research

Volumn 33, Issue 5, 2002, Pages 478-481

  Sánchez, Reyna ^a   Espinosa de los Monteros, Ana Laura ^a   Mendoza, Victoria ^a   Brea, Eduardo ^a   Hernández, Irma ^a   Sosa, Ernesto ^a   Mercado, Moisés ^a,b  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b NONE   (Mexico)

Author keywords

Levothyroxine; Radioiodine scan; Thyroglobulin; Thyroid carcinoma; TSH

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; MALE; THYROID CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; WHOLE BODY SCINTISCANNING;

ADULT; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; THYROID NEOPLASMS; THYROTROPIN; THYROXINE; TIME FACTORS; TRIIODOTHYRONINE;

EID: 0036760290     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(02)00394-6     Document Type: Article

References (11)

1. Schlumberger M.J. Papillary and follicular thyroid carcinoma. N Engl J Med. 338:1998;297-306.
2. Mazzaferri E.L., Kloos R.T. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 86:2001;1447-1463.
3. Edmonds C.J., Hayes S., Kermode J.C., Thompson B.D. Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine. Br J Radiol. 50:1977;799-807.
4. Hilts S.V., Hellman D., Anderson J., Woolfenden J., Van Antwerp J., Paton D. Serial TSH determination after T3 withdrawal or thyroidectomy in the therapy of thyroid carcinoma. J Nucl Med. 20:1979;928-932.
5. 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer. J Clin Endocrinol Metab. 53:1981;1199-1281.
6. 131I uptake postthyroidectomy for thyroid cancer. J Clin Endocrinol Metab. 50:1980;734-739.
7. Schlumberger M., Ricard M., Picini F. Clinical use of recombinant human TSH in thyroid cancer patients. Eur J Endocrinol. 143:2000;557-563.
8. 131I scintiscans and thyroglobulin testing. Thyroid. 6:1996;69-73.
9. Chopra I.J., Sabatino L. Nature and sources of circulating thyroid hormones. Braverman L.E., Utiger R.D. Werner and Ingbar's the thyroid, a fundamental and clinical text. 8th ed:2000;Lippincott, Williams and Wilkins, Philadelphia, PA, USA. 121-135.pp.
10. Hamburger J.I. Serum TSH levels in therapy of thyroid carcinoma. J Nucl Med. 21:1979;492-493.
11. Haugen B.R., Pacini F., Reiners C., Schlumberger M., Ladenson P.W., Sherman S.I., Cooper D.S., Graham K.E., Braverman L.E., Skarulis M.C., Davies T.F., DeGroot L.J., Mazzaferri E.L., Daniels G.H., Ross D.S., Luster M., Samuels M.H., Becker D.V., Maxon H.R. III, Cavalieru R.R., Spencer C.A., McEllin K., Weintraub B.D., Ridgway E.C. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab. 84:1999;3877-3885.